Molecular Cancer Therapeutics
Molecular Cancer Therapeutics is a subscription journal published by American Association for Cancer Research in the United States. OpenAlex counts 12,730 works from it, cited 409,742 times; its h-index is 232. Its two-year mean citedness, which is computed the way the impact factor is, is 1.92: a paper it published in the two years before was cited about 1.92 times last year. It published 612 papers in 2025, up 68% from 365 in 2024.
- Publisher
- American Association for Cancer Research
- Citations per paper
- 1.92 two-year mean, OpenAlex
- h-index
- 232 i10-index 5,356
- Access
- Subscription
- ISSN
- 1535-7163, 1538-8514
- Country
- United States
- Works published
- 12,730 cited 409,742 times
- Papers in 2025
- 612
- Field
- Medicine
- Website
- Journal home ↗
Molecular Cancer Therapeutics year by year
Papers it published each year, and the citations all its papers received that year.
| Year | Papers published | Citations received |
|---|---|---|
| 2026 so far | 159 | 20,704 |
| 2025 | 612 | 24,036 |
| 2024 | 365 | 25,054 |
| 2023 | 719 | 26,212 |
| 2022 | 199 | 26,763 |
| 2021 | 545 | 29,472 |
| 2020 | 252 | 27,868 |
| 2019 | 695 | 23,927 |
What Molecular Cancer Therapeutics publishes
Its most frequent research topics, by OpenAlex's topic classification.
- Lung Cancer Treatments and MutationsPulmonary and Respiratory Medicine · 1,290 papers
- PI3K/AKT/mTOR signaling in cancerMolecular Biology · 1,156 papers
- Cancer-related Molecular PathwaysOncology · 1,028 papers
- Cancer Immunotherapy and BiomarkersOncology · 987 papers
- Monoclonal and Polyclonal Antibodies ResearchImmunology · 905 papers
Questions about Molecular Cancer Therapeutics
What is the impact factor of Molecular Cancer Therapeutics?
Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 1.92 for Molecular Cancer Therapeutics: on average, each paper it published in the two years before was cited about 1.92 times in a year.
What is the h-index of Molecular Cancer Therapeutics?
232, by OpenAlex's count: 232 of its papers have each been cited at least 232 times. Its i10-index is 5,356.
Is Molecular Cancer Therapeutics open access?
Not fully. Molecular Cancer Therapeutics is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.
What is the ISSN of Molecular Cancer Therapeutics?
Its linking ISSN is 1535-7163; all its ISSNs: 1535-7163, 1538-8514.
Who publishes Molecular Cancer Therapeutics?
American Association for Cancer Research, based in the United States.
How many papers does Molecular Cancer Therapeutics publish a year?
612 in 2025, by OpenAlex's count of what it published that year.
What does Molecular Cancer Therapeutics publish?
Its most frequent research topics are Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Cancer-related Molecular Pathways, in the field of Medicine.
Is Molecular Cancer Therapeutics a predatory journal?
Nothing in the scholarly indexes suggests so. Molecular Cancer Therapeutics is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 12,730 works cited 409,742 times. For a journal you do not know, check the red flags with our predatory journal checker.
Is Molecular Cancer Therapeutics indexed in Scopus or Web of Science?
Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (1535-7163): both are free to search. Our guide on checking journal indexing shows each step.
Journals like Molecular Cancer Therapeutics
Other Medicine journals with a similar impact.
Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).